Medicure Inc. (MPH.V)
CAD 0.83
(-7.78%)
CAD 0.83
(-7.78%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 13.98 Million CAD | -3.18% |
| 2022 | 14.88 Million CAD | 0.52% |
| 2021 | 14.8 Million CAD | 11.85% |
| 2020 | 13.23 Million CAD | -37.39% |
| 2019 | 21.14 Million CAD | -19.25% |
| 2018 | 26.18 Million CAD | 30.81% |
| 2017 | 20.01 Million CAD | -6.14% |
| 2016 | 21.32 Million CAD | 41.21% |
| 2015 | 15.1 Million CAD | 91.59% |
| 2014 | 7.88 Million CAD | 96.18% |
| 2013 | 4.01 Million CAD | -0.13% |
| 2012 | 4.02 Million CAD | 8.21% |
| 2011 | 3.71 Million CAD | -5.19% |
| 2010 | 3.92 Million CAD | -28.44% |
| 2009 | 5.48 Million CAD | -43.21% |
| 2008 | 9.65 Million CAD | -77.76% |
| 2007 | 43.38 Million CAD | 18.31% |
| 2006 | 36.67 Million CAD | 178.14% |
| 2005 | 13.18 Million CAD | -16.96% |
| 2004 | 15.87 Million CAD | 146.77% |
| 2003 | 6.43 Million CAD | 45.09% |
| 2002 | 4.43 Million CAD | 9.26% |
| 2001 | 4.05 Million CAD | 20.52% |
| 2000 | 3.36 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.85 Million CAD | 0.31% |
| 2024 Q2 | 4.07 Million CAD | -23.5% |
| 2023 Q2 | 3.74 Million CAD | 7.9% |
| 2023 FY | 14.4 Million CAD | -3.18% |
| 2023 Q1 | 3.47 Million CAD | -11.68% |
| 2023 Q3 | 3.54 Million CAD | -5.21% |
| 2023 Q4 | 3.84 Million CAD | 8.4% |
| 2022 Q4 | 3.92 Million CAD | 29.07% |
| 2022 Q3 | 3.04 Million CAD | -33.23% |
| 2022 Q2 | 4.55 Million CAD | 36.13% |
| 2022 Q1 | 3.34 Million CAD | -3.01% |
| 2022 FY | 14.88 Million CAD | 0.52% |
| 2021 Q2 | 3.81 Million CAD | -3.13% |
| 2021 Q4 | 3.45 Million CAD | -4.27% |
| 2021 Q1 | 3.93 Million CAD | -17.13% |
| 2021 FY | 14.8 Million CAD | 11.85% |
| 2021 Q3 | 3.6 Million CAD | -5.35% |
| 2020 Q3 | 2.92 Million CAD | 59.0% |
| 2020 FY | 13.23 Million CAD | -37.39% |
| 2020 Q1 | 3.72 Million CAD | -17.56% |
| 2020 Q2 | 1.83 Million CAD | -50.66% |
| 2020 Q4 | 4.74 Million CAD | 62.35% |
| 2019 Q1 | 5.98 Million CAD | -34.5% |
| 2019 FY | 21.14 Million CAD | -19.25% |
| 2019 Q2 | 5.26 Million CAD | -11.95% |
| 2019 Q3 | 5.36 Million CAD | 1.9% |
| 2019 Q4 | 4.52 Million CAD | -15.79% |
| 2018 Q3 | 6.08 Million CAD | -0.46% |
| 2018 FY | 26.18 Million CAD | 30.81% |
| 2018 Q1 | 4.84 Million CAD | -8.04% |
| 2018 Q4 | 9.13 Million CAD | 50.01% |
| 2018 Q2 | 6.11 Million CAD | 26.41% |
| 2017 Q3 | 4.38 Million CAD | -62.26% |
| 2017 FY | 20.01 Million CAD | -6.14% |
| 2017 Q1 | 10.49 Million CAD | 62.42% |
| 2017 Q4 | 5.26 Million CAD | 20.02% |
| 2017 Q2 | 11.61 Million CAD | 10.75% |
| 2016 Q3 | 4.74 Million CAD | -22.89% |
| 2016 Q2 | 6.15 Million CAD | 54.78% |
| 2016 FY | 21.32 Million CAD | 41.21% |
| 2016 Q1 | 3.97 Million CAD | -19.13% |
| 2016 Q4 | 6.45 Million CAD | 36.22% |
| 2015 Q2 | 2.68 Million CAD | 8.99% |
| 2015 Q4 | 4.91 Million CAD | -2.45% |
| 2015 Q1 | 2.46 Million CAD | 0.0% |
| 2015 FY | 15.1 Million CAD | 91.59% |
| 2015 Q3 | 5.03 Million CAD | 87.47% |
| 2014 Q3 | 1.38 Million CAD | 21.33% |
| 2014 Q2 | 1.14 Million CAD | 27.87% |
| 2014 Q1 | 893.77 Thousand CAD | -12.84% |
| 2014 FY | 7.88 Million CAD | 96.18% |
| 2013 Q2 | 1.26 Million CAD | 8.47% |
| 2013 FY | 4.01 Million CAD | -0.13% |
| 2013 Q4 | 1.02 Million CAD | 7.24% |
| 2013 Q3 | 956.14 Thousand CAD | -24.22% |
| 2013 Q1 | 1.16 Million CAD | 27.85% |
| 2012 Q1 | 637.53 Thousand CAD | -22.31% |
| 2012 Q2 | 1.11 Million CAD | 75.03% |
| 2012 Q3 | 688.57 Thousand CAD | -38.29% |
| 2012 Q4 | 909.83 Thousand CAD | 32.13% |
| 2012 FY | 4.02 Million CAD | 8.21% |
| 2011 Q2 | 1.38 Million CAD | 40.83% |
| 2011 Q3 | 1.14 Million CAD | -17.3% |
| 2011 Q4 | 820.59 Thousand CAD | -28.28% |
| 2011 Q1 | 982.4 Thousand CAD | 10.63% |
| 2011 FY | 3.71 Million CAD | -5.19% |
| 2010 Q3 | 1.06 Million CAD | 19.73% |
| 2010 Q4 | 887.97 Thousand CAD | -16.85% |
| 2010 FY | 3.92 Million CAD | -28.44% |
| 2010 Q1 | 1.33 Million CAD | -2.51% |
| 2010 Q2 | 891.86 Thousand CAD | -33.16% |
| 2009 Q2 | 3.86 Million CAD | 140.87% |
| 2009 Q3 | 1.88 Million CAD | -51.19% |
| 2009 Q4 | 1.36 Million CAD | -27.43% |
| 2009 FY | 5.48 Million CAD | -43.21% |
| 2009 Q1 | 1.6 Million CAD | -36.99% |
| 2008 Q4 | 2.54 Million CAD | 55.49% |
| 2008 Q3 | 1.63 Million CAD | -35.51% |
| 2008 FY | 9.65 Million CAD | -77.76% |
| 2008 Q1 | 9.67 Million CAD | -39.15% |
| 2008 Q2 | 2.53 Million CAD | -73.77% |
| 2007 Q4 | 15.9 Million CAD | 4.21% |
| 2007 Q2 | 14.81 Million CAD | 38.27% |
| 2007 Q1 | 10.71 Million CAD | 51.85% |
| 2007 FY | 43.38 Million CAD | 18.31% |
| 2007 Q3 | 15.26 Million CAD | 3.01% |
| 2006 Q1 | 2.76 Million CAD | -22.46% |
| 2006 Q4 | 7.05 Million CAD | 72.85% |
| 2006 Q2 | 3 Million CAD | 8.88% |
| 2006 Q3 | 4.08 Million CAD | 35.76% |
| 2006 FY | 36.67 Million CAD | 178.14% |
| 2005 Q3 | 3.85 Million CAD | -23.2% |
| 2005 Q4 | 3.56 Million CAD | -7.55% |
| 2005 FY | 13.18 Million CAD | -16.96% |
| 2005 Q1 | 4.48 Million CAD | 20.55% |
| 2005 Q2 | 5.01 Million CAD | 11.78% |
| 2004 Q4 | 3.72 Million CAD | 36.81% |
| 2004 FY | 15.87 Million CAD | 146.77% |
| 2004 Q2 | 2.3 Million CAD | 41.28% |
| 2004 Q3 | 2.72 Million CAD | 18.17% |
| 2004 Q1 | 1.63 Million CAD | 22.82% |
| 2003 FY | 6.43 Million CAD | 45.09% |
| 2003 Q1 | 986.07 Thousand CAD | -19.82% |
| 2003 Q2 | 945.3 Thousand CAD | -4.13% |
| 2003 Q4 | 1.32 Million CAD | 13.09% |
| 2003 Q3 | 1.17 Million CAD | 24.16% |
| 2002 Q3 | 1.27 Million CAD | 0.0% |
| 2002 FY | 4.43 Million CAD | 9.26% |
| 2002 Q4 | 1.22 Million CAD | -3.45% |
| 2001 FY | 4.05 Million CAD | 20.52% |
| 2000 FY | 3.36 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 2.96 Million CAD | -371.972% |
| CanadaBis Capital Inc. | 7.1 Million CAD | -96.84% |
| Decibel Cannabis Company Inc. | 40.44 Million CAD | 65.414% |
| Delivra Health Brands Inc. | 7.1 Million CAD | -96.779% |
| Entourage Health Corp. | 3.7 Million CAD | -277.296% |
| Lifeist Wellness Inc. | 17.59 Million CAD | 20.491% |
| Cannara Biotech Inc. | 15.34 Million CAD | 8.824% |
| PharmaCielo Ltd. | 8.33 Million CAD | -67.893% |
| Rubicon Organics Inc. | 14.22 Million CAD | 1.654% |
| BioSyent Inc. | 17.6 Million CAD | 20.555% |
| Voyageur Pharmaceuticals Ltd. | 1.22 Million CAD | -1045.745% |